GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
51.02
-1.35 (-2.58%)
At close: Nov 16, 2026, 4:00 PM EST
51.51
+0.49 (0.96%)
After-hours: Nov 16, 2026, 7:47 PM EST
GeneDx Holdings Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, GeneDx Holdings stock has a consensus rating of "Strong Buy" and an average price target of $82. The average 1-year stock price forecast is 60.72% higher than the current stock price, while the lowest is $65 (+27.40%) and the highest is $102 (+99.92%).
Price Target: $82 (+60.72%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for GeneDx Holdings stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 7 | 7 | 7 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Buy Maintains $103 → $66 | Buy | Maintains | $103 → $66 | +29.36% | Nov 13, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $95 | Buy | Maintains | $95 | +86.20% | Nov 10, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $83 | Buy | Reiterates | $83 | +62.68% | Nov 10, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $90 | Buy | Reiterates | $90 | +76.40% | Nov 10, 2026 |
| BTIG | BTIG | Buy Reiterates $90 → $85 | Buy | Reiterates | $90 → $85 | +66.60% | Nov 10, 2026 |
Financial Forecast
Revenue This Year
476.27M
from 427.54M
Increased by 11.40%
Revenue Next Year
572.56M
from 476.27M
Increased by 20.22%
EPS This Year
0.42
from 1.40
Decreased by -70.24%
EPS Next Year
1.12
from 0.42
Increased by 169.28%
EPS and Forward PE are based on non-GAAP adjusted numbers.